Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 56
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    An initial exploration of in-situ underwater genetic sequencing

    Our goal is to adapt portable genome sequencing technology for high-pressure, underwater environments. Currently...

    Sustainable bio-mining of rare Earth elements utilizing microorganism biotechnology

    Rare Earth Elements (REE) are highly sought after for their powerful magnetic properties and energy efficient...

    Spatially controlling attachment of functional proteins to bacterial cellulose using optogenetics

    The bacterium Komagataeibacter rhaeticus has the ability to naturally produce bacterial cellulose (BC) which...

    Backer Badge Funded